Barclays raised the firm’s price target on Goldman Sachs (GS) to $760 from $713 and keeps an Overweight rating on the shares following the Q4

Goldman Sachs partnered with Apple in 2019 to launch the Apple Card. The Apple Card, while innovative in its integration with Apple’s ecosystem, proved a costly for Goldman. Barclays and Synchrony Financial are reportedly the top contenders of replacing Goldman.

Apple is in talks with Barclays to replace Goldman Sachs as the tech giant’s credit card partner, says two sources familiar with the matter, as the Wall Street giant steps back from its consumer finance ambitions.

Analyst Betsy Graseck from Morgan Stanley maintained a Buy rating on Goldman Sachs Group (GS – Research Report) and increased the price target

Apple is exploring partnerships with Barclays and Synchrony to replace Goldman Sachs as its credit card partner as Goldman scales back its consumer finance ambitions.

It's been Goldman Sachs in the background since the Apple Card's launch in 2019. Ever since its introduction in 2019, the Apple Card has been powered

The Apple Card, which has now been available in the USA for over five years, needs a new bank. Now there are other candidates.

This week’s Apple headlines; iPhone Air leaks, new iPhone SE details, iPhone 15 special offers, Ai headlines paused, Apple Card’s new home, Tim Cook’s inauguration seat, and

Goldman Sachs Group Inc, SPDR® S&P 500, TJX Companies Inc, Natural Gas Futures. Read Investing.com (Jesse Cohen)'s latest article on Investing.com UK.

Apple is in talks with two major financial firms, as it looks for a new Apple Card partner to replace Goldman Sachs.

Medical credit cards are increasingly pushed on patients across America as the costs of health, dental, and veterinary procedures rise. CareCredit had 12 million cardholders and 270,000 participating providers in 2024,